首页 > 最新文献

Actas urologicas espanolas最新文献

英文 中文
La relación entre el virus del papiloma humano (VPH) y el diagnóstico de cáncer de vejiga: revisión sistemática y metaanálisis 人类乳头瘤病毒(HPV)与膀胱癌诊断之间的关系:系统回顾与荟萃分析
IF 1.2 4区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2024-07-01 DOI: 10.1016/j.acuro.2024.01.013
I.J. Otero-Muriel , S. Jiménez Giraldo , H.A. García-Perdomo

Background

Bladder cancer (BC) is the seventh most common cancer worldwide. Not every infection ends as cancer, although the HPV-induced carcinogenesis is a complex process consequence of inflammation. To determine the association between human papillomavirus (HPV) and the diagnosis of bladder cancer.

Methods

We carried out a systematic review according to Cochrane and PRISMA recommendations. We searched in EMBASE, Medline (Ovid), and The Cochrane Central Register of Controlled Trials (CENTRAL), from inception to nowadays. We included case-control studies. The risk of bias assessment was performed based on QUADAS2. We performed a random effect Meta-analysis.

Results

We included 14 studies in qualitative and quantitative analysis. There was mainly a low risk of bias. We finally found a strong association between the presence of HPV and bladder cancer diagnosis (OR 4.18 95%CI 2.63 to 6.66; I2 = 40%).

Conclusions

HPV is currently associated with the diagnosis of bladder cancer.

背景膀胱癌(BC)是全球第七大常见癌症。尽管人乳头瘤病毒(HPV)诱发的癌变是一个复杂的炎症过程,但并非每次感染都会导致癌症。为了确定人类乳头瘤病毒(HPV)与膀胱癌诊断之间的关联,我们根据 Cochrane 和 PRISMA 建议进行了一项系统综述。我们检索了 EMBASE、Medline (Ovid) 和 Cochrane 对照试验中央注册中心 (CENTRAL),检索时间从开始到现在。我们纳入了病例对照研究。偏倚风险评估基于 QUADAS2 进行。我们进行了随机效应 Meta 分析。主要存在低偏倚风险。我们最终发现,HPV 的存在与膀胱癌诊断之间存在密切联系(OR 4.18 95%CI 2.63 至 6.66;I2 = 40%)。
{"title":"La relación entre el virus del papiloma humano (VPH) y el diagnóstico de cáncer de vejiga: revisión sistemática y metaanálisis","authors":"I.J. Otero-Muriel ,&nbsp;S. Jiménez Giraldo ,&nbsp;H.A. García-Perdomo","doi":"10.1016/j.acuro.2024.01.013","DOIUrl":"10.1016/j.acuro.2024.01.013","url":null,"abstract":"<div><h3>Background</h3><p>Bladder cancer (BC) is the seventh most common cancer worldwide. Not every infection ends as cancer, although the HPV-induced carcinogenesis is a complex process consequence of inflammation. To determine the association between human papillomavirus (HPV) and the diagnosis of bladder cancer.</p></div><div><h3><em>Methods</em></h3><p>We carried out a systematic review according to Cochrane and PRISMA recommendations. We searched in EMBASE, Medline (Ovid), and The Cochrane Central Register of Controlled Trials (CENTRAL), from inception to nowadays. We included case-control studies. The risk of bias assessment was performed based on QUADAS2. We performed a random effect Meta-analysis.</p></div><div><h3>Results</h3><p>We included 14 studies in qualitative and quantitative analysis. There was mainly a low risk of bias. We finally found a strong association between the presence of HPV and bladder cancer diagnosis (OR 4.18 95%CI 2.63 to 6.66; I2<!--> <!-->=<!--> <!-->40%).</p></div><div><h3>Conclusions</h3><p>HPV is currently associated with the diagnosis of bladder cancer.</p></div>","PeriodicalId":7145,"journal":{"name":"Actas urologicas espanolas","volume":"48 6","pages":"Pages 427-436"},"PeriodicalIF":1.2,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140467543","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Abordaje laparoscópico en pacientes con pielonefritis xantogranulomatosa y pionefrosis 黄疽性肾盂肾炎和肾盂积水患者的腹腔镜治疗方法
IF 1.2 4区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2024-07-01 DOI: 10.1016/j.acuro.2024.01.010
T. Telecan , I. Andras , N. Crousen , E.D. Cata , P. Medan , D.V. Stanca , A. Territo , I. Coman , N. Crisan

Introduction

Xanthogranulomatous pyelonephritis (XGPN) is a rare form of chronic renal inflammation, caused by long-term obstruction of the urinary tract. Pyonephrosis is a severe suppurative complication of acute obstructive pyelonephritis. Although minimally invasive approaches have many advantages, the safe dissection of the kidney may not be always achievable.

Materials and methods

We reviewed 27 cases diagnosed with either XGPN or pyonephrosis, who underwent laparoscopic total nephrectomy between October 2016 and March 2022 in our department. All interventions were performed using the Karl Storz 3 D laparoscopic system. The surgical approach was standard transperitoneal nephrectomy for the majority of XGPN, while pyonephrosis cases were carried out in a retroperitoneally. All procedures were performed or supervised by the same surgeon.

Results

The mean operative time was 269.85 minutes (range 145–360). The mean hemoglobin drop after surgery was 1.41 g/dl (range 0.3–2.3 g/dl). Difficult dissection was encountered in 13 cases (48.14%). Nine out of 13 interventions were carried out in a complete intracorporeal fashion, while conversion to open surgery was needed in 4 cases. Vascular complications involving the major blood vessels comprised of one case of inferior vena cava (IVC) tear. Digestive tract-related complications comprised two fistulas of the descending colon and one peritoneal breach. Multiorgan resection was performed in 6 cases.

Conclusion

Total nephrectomy in cases of XGPN and pyonephrosis is a challenging procedure. The laparoscopic approach is feasible, as most complications are resolved intracorporeally. However, it may remain reserved for large-volume centers with experienced surgeons.

导言:黄原肉芽肿性肾盂肾炎(XGPN)是一种罕见的慢性肾脏炎症,由尿路长期梗阻引起。肾盂积脓是急性梗阻性肾盂肾炎的一种严重化脓性并发症。虽然微创方法有很多优点,但并非总能安全地解剖肾脏。材料和方法我们回顾了 2016 年 10 月至 2022 年 3 月期间在我科接受腹腔镜全肾切除术的 27 例诊断为 XGPN 或肾盂积水的病例。所有手术均使用 Karl Storz 3 D 腹腔镜系统进行。大多数XGPN的手术方式为标准的经腹膜肾切除术,而肾盂肾积水病例则在腹膜后进行。结果平均手术时间为269.85分钟(145-360分钟不等)。术后血红蛋白平均下降 1.41 g/dl(范围 0.3-2.3 g/dl)。有 13 例(48.14%)患者遇到了剥离困难。13 例手术中有 9 例完全在体腔内完成,4 例需要转为开放手术。涉及大血管的并发症包括一例下腔静脉(IVC)撕裂。消化道相关并发症包括两例降结肠瘘和一例腹膜破损。结论XGPN和肾盂肾炎病例的全肾切除术是一项具有挑战性的手术。腹腔镜方法是可行的,因为大多数并发症都能在体腔内解决。然而,腹腔镜手术仍需在拥有经验丰富外科医生的大型医疗中心进行。
{"title":"Abordaje laparoscópico en pacientes con pielonefritis xantogranulomatosa y pionefrosis","authors":"T. Telecan ,&nbsp;I. Andras ,&nbsp;N. Crousen ,&nbsp;E.D. Cata ,&nbsp;P. Medan ,&nbsp;D.V. Stanca ,&nbsp;A. Territo ,&nbsp;I. Coman ,&nbsp;N. Crisan","doi":"10.1016/j.acuro.2024.01.010","DOIUrl":"10.1016/j.acuro.2024.01.010","url":null,"abstract":"<div><h3>Introduction</h3><p>Xanthogranulomatous pyelonephritis (XGPN) is a rare form of chronic renal inflammation, caused by long-term obstruction of the urinary tract. Pyonephrosis is a severe suppurative complication of acute obstructive pyelonephritis. Although minimally invasive approaches have many advantages, the safe dissection of the kidney may not be always achievable.</p></div><div><h3>Materials and methods</h3><p>We reviewed 27 cases diagnosed with either XGPN or pyonephrosis, who underwent laparoscopic total nephrectomy between October 2016 and March 2022 in our department. All interventions were performed using the Karl Storz 3<!--> <!-->D laparoscopic system. The surgical approach was standard transperitoneal nephrectomy for the majority of XGPN, while pyonephrosis cases were carried out in a retroperitoneally. All procedures were performed or supervised by the same surgeon.</p></div><div><h3>Results</h3><p>The mean operative time was 269.85<!--> <!-->minutes (range 145–360). The mean hemoglobin drop after surgery was 1.41<!--> <!-->g/dl (range 0.3–2.3<!--> <!-->g/dl). Difficult dissection was encountered in 13 cases (48.14%). Nine out of 13 interventions were carried out in a complete intracorporeal fashion, while conversion to open surgery was needed in 4 cases. Vascular complications involving the major blood vessels comprised of one case of inferior vena cava (IVC) tear. Digestive tract-related complications comprised two fistulas of the descending colon and one peritoneal breach. Multiorgan resection was performed in 6 cases.</p></div><div><h3>Conclusion</h3><p>Total nephrectomy in cases of XGPN and pyonephrosis is a challenging procedure. The laparoscopic approach is feasible, as most complications are resolved intracorporeally. However, it may remain reserved for large-volume centers with experienced surgeons.</p></div>","PeriodicalId":7145,"journal":{"name":"Actas urologicas espanolas","volume":"48 6","pages":"Pages 476-483"},"PeriodicalIF":1.2,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139830192","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluación clínica y tratamiento en hombres con testosterona baja y cáncer de próstata 男性睾酮低和前列腺癌患者的临床评估和治疗
IF 1.2 4区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2024-07-01 DOI: 10.1016/j.acuro.2023.09.005
B.M. Ljubetic, F. Parada, J.M. Flores

Introduction

A high prevalence of low testosterone levels has been reported in men with prostate cancer. The use of testosterone therapy in men with a history of prostate cancer is still controversial, and there is uncertainty regarding the management of these patients.

Methods

We analyzed the European and American guidelines on this topic and presented the clinical experience in the management of patients with low testosterone levels and a history of prostate cancer in one of the world's leading cancer centers.

Results

According to the published evidence to date, testosterone therapy in men with prostate cancer does not increase the risk of prostate cancer recurrence in the short and medium term, but there is a lack of data on the long term. Symptomatic men with low testosterone levels who are candidates for this therapy need a thorough clinical evaluation before commencing testosterone therapy. Evaluation of prostate cancer history including type of treatment administered, pathologic stage of prostate cancer and prostate specific antigen should be requested before and during testosterone treatment to assess its trend.

Conclusion

Prostate-specific antigen should remain undetectable after radical prostatectomy or stable after radiotherapy. Otherwise, it would be a sign of uncontrolled prostate cancer, and the patient may require cessation of testosterone therapy and referral to oncology for further evaluation.

引言 据报道,前列腺癌男性患者中睾酮水平低的比例很高。方法我们分析了欧洲和美国有关这一主题的指南,并介绍了世界领先的癌症中心之一在治疗睾酮水平低且有前列腺癌病史的患者方面的临床经验。结果根据迄今为止已发表的证据,前列腺癌男性患者接受睾酮治疗在短期和中期内不会增加前列腺癌复发的风险,但缺乏长期数据。睾酮水平低且有症状的男性患者在开始睾酮治疗前需要进行全面的临床评估。在睾酮治疗前和治疗期间,应评估前列腺癌病史,包括治疗类型、前列腺癌病理分期和前列腺特异性抗原,以评估其变化趋势。前列腺特异性抗原在根治性前列腺切除术后应保持检测不到,或在放疗后保持稳定,否则将是前列腺癌未得到控制的迹象,患者可能需要停止睾酮治疗,并转到肿瘤科做进一步评估。
{"title":"Evaluación clínica y tratamiento en hombres con testosterona baja y cáncer de próstata","authors":"B.M. Ljubetic,&nbsp;F. Parada,&nbsp;J.M. Flores","doi":"10.1016/j.acuro.2023.09.005","DOIUrl":"10.1016/j.acuro.2023.09.005","url":null,"abstract":"<div><h3>Introduction</h3><p>A high prevalence of low testosterone levels has been reported in men with prostate cancer. The use of testosterone therapy in men with a history of prostate cancer is still controversial, and there is uncertainty regarding the management of these patients.</p></div><div><h3>Methods</h3><p>We analyzed the European and American guidelines on this topic and presented the clinical experience in the management of patients with low testosterone levels and a history of prostate cancer in one of the world's leading cancer centers.</p></div><div><h3>Results</h3><p>According to the published evidence to date, testosterone therapy in men with prostate cancer does not increase the risk of prostate cancer recurrence in the short and medium term, but there is a lack of data on the long term. Symptomatic men with low testosterone levels who are candidates for this therapy need a thorough clinical evaluation before commencing testosterone therapy. Evaluation of prostate cancer history including type of treatment administered, pathologic stage of prostate cancer and prostate specific antigen should be requested before and during testosterone treatment to assess its trend.</p></div><div><h3>Conclusion</h3><p>Prostate-specific antigen should remain undetectable after radical prostatectomy or stable after radiotherapy. Otherwise, it would be a sign of uncontrolled prostate cancer, and the patient may require cessation of testosterone therapy and referral to oncology for further evaluation.</p></div>","PeriodicalId":7145,"journal":{"name":"Actas urologicas espanolas","volume":"48 6","pages":"Pages 410-415"},"PeriodicalIF":1.2,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135811072","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Asociación entre COVID-19 y el aumento en la incidencia de síntomas de vejiga hiperactiva en pacientes femeninas: un análisis retrospectivo COVID-19 与女性患者膀胱过度活动症状发病率增加之间的关系:回顾性分析
IF 1.2 4区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2024-07-01 DOI: 10.1016/j.acuro.2023.11.004
A. Coşkun , K. Erdem , U. Can

Introduction and objectives

To investigate female patients’ post-COVID-19 voiding symptoms and to research how they relate to overactive bladder (OAB).

Patients

One hundred and forty patients aged 20-50 years who were hospitalised and discharged due to COVID-19 at Kartal Dr. Lütfi Kırdar City Hospital between 2021 and 2022 and 50 patients with a history of COVID-19 among two hundred female patients who presented to the urology outpatient clinic with symptoms related to OAB were retrospectively analysed. Bladder diary, overactive bladder symptom score (OABSS), uroflowmetry values and time of onset of symptoms of symptomatic patients were recorded for all patients. Disease-free individuals for control purposes were not included in the study.

Results

It was observed that 38% of 140 hospitalized patients had a symptomatic change related to OAB, and there was a significant difference in voiding diary, OABSS, and uroflowmetry Qmax values between symptomatic and non-symptomatic patients after COVID-19 (p: 0.001). There was a significant difference between the pre-COVID-19 (estimated) and post-COVID-19 (current) voiding diary and OABSS values of all symptomatic patients (with and without a history of hospitalization) (p: 0.001). When these two groups were compared with each other, there was a significant difference between the post-COVID-19 voiding diary, OABSS values, and the meantime to the onset of symptoms in inpatients and outpatients (p: 0.001).

Conclusion

COVID-19 may be associated with urgency/urge incontinence and overactive bladder in female patients.

患者回顾性分析了2021年至2022年期间因COVID-19在卡尔塔尔-吕特菲-克尔达尔博士市医院住院并出院的140名20-50岁患者,以及因OAB相关症状到泌尿科门诊就诊的200名女性患者中50名有COVID-19病史的患者。所有患者的膀胱日记、膀胱过度活动症状评分(OABSS)、尿流率测量值和有症状患者的发病时间均被记录在案。结果发现,140 名住院患者中有 38% 出现了与 OAB 相关的症状变化,在 COVID-19 治疗后,有症状和无症状患者的排尿日记、OABSS 和尿流率 Qmax 值均有显著差异(P:0.001)。所有症状患者(有住院史和无住院史)在 COVID-19 前(估计值)和 COVID-19 后(当前值)的排尿日记和 OABSS 值之间存在明显差异(P:0.001)。结论COVID-19 可能与女性患者的尿急/尿急尿失禁和膀胱过度活动症有关。
{"title":"Asociación entre COVID-19 y el aumento en la incidencia de síntomas de vejiga hiperactiva en pacientes femeninas: un análisis retrospectivo","authors":"A. Coşkun ,&nbsp;K. Erdem ,&nbsp;U. Can","doi":"10.1016/j.acuro.2023.11.004","DOIUrl":"https://doi.org/10.1016/j.acuro.2023.11.004","url":null,"abstract":"<div><h3>Introduction and objectives</h3><p>To investigate female patients’ post-COVID-19 voiding symptoms and to research how they relate to overactive bladder (OAB).</p></div><div><h3>Patients</h3><p>One hundred and forty patients aged 20-50 years who were hospitalised and discharged due to COVID-19 at Kartal Dr. Lütfi Kırdar City Hospital between 2021 and 2022 and 50 patients with a history of COVID-19 among two hundred female patients who presented to the urology outpatient clinic with symptoms related to OAB were retrospectively analysed. Bladder diary, overactive bladder symptom score (OABSS), uroflowmetry values and time of onset of symptoms of symptomatic patients were recorded for all patients. Disease-free individuals for control purposes were not included in the study.</p></div><div><h3>Results</h3><p>It was observed that 38% of 140 hospitalized patients had a symptomatic change related to OAB, and there was a significant difference in voiding diary, OABSS, and uroflowmetry Q<sub>max</sub> values between symptomatic and non-symptomatic patients after COVID-19 (p: 0.001). There was a significant difference between the pre-COVID-19 (estimated) and post-COVID-19 (current) voiding diary and OABSS values of all symptomatic patients (with and without a history of hospitalization) (p: 0.001). When these two groups were compared with each other, there was a significant difference between the post-COVID-19 voiding diary, OABSS values, and the meantime to the onset of symptoms in inpatients and outpatients (p: 0.001).</p></div><div><h3>Conclusion</h3><p>COVID-19 may be associated with urgency/urge incontinence and overactive bladder in female patients.</p></div>","PeriodicalId":7145,"journal":{"name":"Actas urologicas espanolas","volume":"48 6","pages":"Pages 454-460"},"PeriodicalIF":1.2,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141479680","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
El efecto de la electroacupuntura en la gravedad y los síntomas de la incontinencia urinaria de esfuerzo en mujeres: revisión sistemática y metaanálisis de ensayos controlados aleatorizados 电针对女性压力性尿失禁严重程度和症状的影响:随机对照试验的系统回顾和荟萃分析
IF 1.2 4区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2024-07-01 DOI: 10.1016/j.acuro.2024.01.011
F.Ş. Bilgiç , N. Gençtürk , B. Arikan

Introduction

Stress Urinary Incontinence is a condition that impairs the quality of life in women and randomized controlled trials of electroacupuncture for stress urinary incontinence have been conducted.

Objective

The aim of this systematic review and meta-analysis was to examine the effect of electroacupuncture on the severity and symptoms of urinary incontinence in women with stress urinary incontinence.

Methods

Literature searches were conducted in PubMed, CINAHL, Scopus and Science Citation Index until November 2023. This study was based on the recommendations of the Cochrane guidelines. Data were analyzed using the Review Manager computer program (Version 5.4). The methodological quality of the studies was assessed using the RoB-2 tool.

Results

The analysis included 888 women with stress urinary incontinence and three studies. In women with stress urinary incontinence, electroacupuncture intervention improved urinary incontinence severity and quality of life (MD:-2.37, 95% CI:-3.29 to 1.45, Z = 5.07,p< 0. 001), urinary leakage (SMD:-0.79, 95% CI:-1.02 to -0.55, Z = 6.60,p = 0.001) and incontinence episode frequency (SMD:-2.24, 95%CI:-4.17 to -0.32, Z = 2.29,p< 0.02).

Conclusion

In women with stress urinary incontinence, electroacupuncture intervention decreased the severity of urinary incontinence and improved the quality of life. Symptoms related to urinary incontinence were found to decrease urinary leakage and incontinence episode frequency. The studies included in the analysis were determined to be low-risk studies in quality assessment.

简介:压力性尿失禁是一种影响女性生活质量的疾病,目前已开展了电针治疗压力性尿失禁的随机对照试验。本系统综述和荟萃分析旨在研究电针对压力性尿失禁女性尿失禁严重程度和症状的影响。本研究以 Cochrane 指南的建议为基础。数据使用 Review Manager 计算机程序(5.4 版)进行分析。结果分析包括 888 名压力性尿失禁女性和三项研究。在患有压力性尿失禁的妇女中,电针干预改善了尿失禁的严重程度和生活质量(MD:-2.37, 95% CI:-3.29 to 1.45, Z = 5.07,p< 0.001) 和尿失禁发作频率 (SMD:-2.24, 95%CI:-4.17 to -0.32, Z = 2.29,p< 0.02)。与尿失禁相关的症状可减少漏尿和尿失禁发作频率。纳入分析的研究在质量评估中被确定为低风险研究。
{"title":"El efecto de la electroacupuntura en la gravedad y los síntomas de la incontinencia urinaria de esfuerzo en mujeres: revisión sistemática y metaanálisis de ensayos controlados aleatorizados","authors":"F.Ş. Bilgiç ,&nbsp;N. Gençtürk ,&nbsp;B. Arikan","doi":"10.1016/j.acuro.2024.01.011","DOIUrl":"10.1016/j.acuro.2024.01.011","url":null,"abstract":"<div><h3>Introduction</h3><p>Stress Urinary Incontinence is a condition that impairs the quality of life in women and randomized controlled trials of electroacupuncture for stress urinary incontinence have been conducted.</p></div><div><h3>Objective</h3><p>The aim of this systematic review and meta-analysis was to examine the effect of electroacupuncture on the severity and symptoms of urinary incontinence in women with stress urinary incontinence.</p></div><div><h3>Methods</h3><p>Literature searches were conducted in PubMed, CINAHL, Scopus and Science Citation Index until November 2023. This study was based on the recommendations of the Cochrane guidelines. Data were analyzed using the Review Manager computer program (Version 5.4). The methodological quality of the studies was assessed using the RoB-2 tool.</p></div><div><h3>Results</h3><p>The analysis included 888 women with stress urinary incontinence and three studies. In women with stress urinary incontinence, electroacupuncture intervention improved urinary incontinence severity and quality of life (MD:-2.37, 95% CI:-3.29 to 1.45, Z<!--> <!-->=<!--> <!-->5.07,p&lt;<!--> <!-->0. 001), urinary leakage (SMD:-0.79, 95% CI:-1.02 to -0.55, Z<!--> <!-->=<!--> <!-->6.60,p<!--> <!-->=<!--> <!-->0.001) and incontinence episode frequency (SMD:-2.24, 95%CI:-4.17 to -0.32, Z<!--> <!-->=<!--> <!-->2.29,p&lt;<!--> <!-->0.02).</p></div><div><h3>Conclusion</h3><p>In women with stress urinary incontinence, electroacupuncture intervention decreased the severity of urinary incontinence and improved the quality of life. Symptoms related to urinary incontinence were found to decrease urinary leakage and incontinence episode frequency. The studies included in the analysis were determined to be low-risk studies in quality assessment.</p></div>","PeriodicalId":7145,"journal":{"name":"Actas urologicas espanolas","volume":"48 6","pages":"Pages 437-447"},"PeriodicalIF":1.2,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139966013","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Resultados iniciales del tratamiento con láser tulio pulsado (Dornier®) en la litiasis renal y ureteral con ureteroscopia 脉冲铥激光 (Dornier®) 治疗肾和输尿管结石并配合输尿管镜检查的初步结果
IF 1.2 4区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2024-07-01 DOI: 10.1016/j.acuro.2024.02.001
M.C. Cano-García , C. Abad Rodríguez-Hesles , V. Yuste-Mascarós , M.Á. Arrabal Polo
{"title":"Resultados iniciales del tratamiento con láser tulio pulsado (Dornier®) en la litiasis renal y ureteral con ureteroscopia","authors":"M.C. Cano-García ,&nbsp;C. Abad Rodríguez-Hesles ,&nbsp;V. Yuste-Mascarós ,&nbsp;M.Á. Arrabal Polo","doi":"10.1016/j.acuro.2024.02.001","DOIUrl":"https://doi.org/10.1016/j.acuro.2024.02.001","url":null,"abstract":"","PeriodicalId":7145,"journal":{"name":"Actas urologicas espanolas","volume":"48 6","pages":"Pages 484-485"},"PeriodicalIF":1.2,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141479681","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Abordaje de la neuralgia del nervio pudendo mediante corriente eléctrica. Una revisión sistemática 使用电流治疗阴部神经痛。系统回顾
IF 1.2 4区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2024-07-01 DOI: 10.1016/j.acuro.2024.01.002
L. Piñeiro-Franco, A. Alonso-Calvete, I. Da Cuña-Carrera

Introduction and objective

Pudendal neuralgia is a severely intense, painful, neuropathic condition, involving the dermatome of the pudendal nerve (S2, S3, S4). The diagnosis is complex and usually takes many years to be made. Techniques that use electrical current have been shown to decrease pain and improve quality of life in patients with this condition. The aim of this review was to analyze the existing literature on the effects of electrical current in the treatment of patients with pudendal neuralgia.

Material and methods

A literature search was carried out in PubMed, Cinahl, Medline, Cochrane Library, ENFISPO, PEDro, Scopus and Web of Science databases, using the search terms “Electric Stimulation Therapy”, “pudendal neuralgia” and “pudendal nerve entrapment”.

Results

The most frequently repeated intervention is pulsed radiofrequency. Other techniques used are transcutaneous electrical nerve stimulation, pulsed electromagnetic field therapy and neuromodulation. All studies show significant improvement in pain, analgesic intake, depression-anxiety or quality of life.

Conclusions

The application of electrical current seems to be effective in the management of pudendal neuralgia. The scientific evidence is scarce, of poor methodological quality, and its use is based on the efficacy demonstrated in other indications of chronic pain.

导言和目的 裸神经痛是一种剧烈疼痛的神经病理性症状,累及裸神经皮节(S2、S3、S4)。该病诊断复杂,通常需要多年才能确诊。使用电流的技术已被证明可以减轻疼痛并改善该病患者的生活质量。本综述旨在分析现有文献中有关电流治疗阴茎神经痛患者的效果。材料和方法在 PubMed、Cinahl、Medline、Cochrane Library、ENFISPO、PEDro、Scopus 和 Web of Science 数据库中进行文献检索,检索词为 "电刺激疗法"、"阴茎神经痛 "和 "阴茎神经卡压"。其他常用技术包括经皮神经电刺激、脉冲电磁场疗法和神经调控。所有研究均显示,疼痛、镇痛药摄入量、抑郁焦虑或生活质量均有明显改善。科学证据很少,方法质量不高,其使用是基于其他慢性疼痛适应症的疗效。
{"title":"Abordaje de la neuralgia del nervio pudendo mediante corriente eléctrica. Una revisión sistemática","authors":"L. Piñeiro-Franco,&nbsp;A. Alonso-Calvete,&nbsp;I. Da Cuña-Carrera","doi":"10.1016/j.acuro.2024.01.002","DOIUrl":"https://doi.org/10.1016/j.acuro.2024.01.002","url":null,"abstract":"<div><h3>Introduction and objective</h3><p>Pudendal neuralgia is a severely intense, painful, neuropathic condition, involving the dermatome of the pudendal nerve (S2, S3, S4). The diagnosis is complex and usually takes many years to be made. Techniques that use electrical current have been shown to decrease pain and improve quality of life in patients with this condition. The aim of this review was to analyze the existing literature on the effects of electrical current in the treatment of patients with pudendal neuralgia.</p></div><div><h3>Material and methods</h3><p>A literature search was carried out in PubMed, Cinahl, Medline, Cochrane Library, ENFISPO, PEDro, Scopus and Web of Science databases, using the search terms “Electric Stimulation Therapy”, “pudendal neuralgia” and “pudendal nerve entrapment”.</p></div><div><h3>Results</h3><p>The most frequently repeated intervention is pulsed radiofrequency. Other techniques used are transcutaneous electrical nerve stimulation, pulsed electromagnetic field therapy and neuromodulation. All studies show significant improvement in pain, analgesic intake, depression-anxiety or quality of life.</p></div><div><h3>Conclusions</h3><p>The application of electrical current seems to be effective in the management of pudendal neuralgia. The scientific evidence is scarce, of poor methodological quality, and its use is based on the efficacy demonstrated in other indications of chronic pain.</p></div>","PeriodicalId":7145,"journal":{"name":"Actas urologicas espanolas","volume":"48 6","pages":"Pages 416-426"},"PeriodicalIF":1.2,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141479682","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Biomarcadores en el trasplante renal: ¿qué podemos esperar? 肾移植中的生物标志物:我们能期待什么?
IF 1.2 4区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2024-07-01 DOI: 10.1016/j.acuro.2023.10.012
A. López-Abad , A. Piana , T. Prudhomme , B. Bañuelos Marco , M.I. Dönmez , A. Pecoraro , R. Boissier , R. Campi , A. Breda , A. Territo , en representación del grupo de trabajo de trasplante renal de la sección de Jóvenes Urólogos Académicos (YAU) de la Asociación Europea de Urología (EAU)
{"title":"Biomarcadores en el trasplante renal: ¿qué podemos esperar?","authors":"A. López-Abad ,&nbsp;A. Piana ,&nbsp;T. Prudhomme ,&nbsp;B. Bañuelos Marco ,&nbsp;M.I. Dönmez ,&nbsp;A. Pecoraro ,&nbsp;R. Boissier ,&nbsp;R. Campi ,&nbsp;A. Breda ,&nbsp;A. Territo ,&nbsp;en representación del grupo de trabajo de trasplante renal de la sección de Jóvenes Urólogos Académicos (YAU) de la Asociación Europea de Urología (EAU)","doi":"10.1016/j.acuro.2023.10.012","DOIUrl":"10.1016/j.acuro.2023.10.012","url":null,"abstract":"","PeriodicalId":7145,"journal":{"name":"Actas urologicas espanolas","volume":"48 6","pages":"Pages 407-409"},"PeriodicalIF":1.2,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139305259","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nuevas pautas de actuación en la hiperplasia benigna de próstata en la Comunidad Valenciana: un estudio de vida real 巴伦西亚社区良性前列腺增生症行动新指南:一项真实生活研究
IF 1.2 4区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2024-07-01 DOI: 10.1016/j.acuro.2023.11.006
J. Navarro-Pérez , E. López Alcina , J. Calabuig Pérez , F. Brotons Muntó , A. Martínez , L. Vallejo , J. Jiménez

Introduction and objectives

A training program was developed to increase general practitioners’ engagement in the optimal management of benign prostatic hyperplasia (BPH). The goal of this study was to evaluate changes in BPH management after the implementation of a training program.

Material and methods

This observational retrospective cohort study was conducted between 2019 and 2020. Aggregated data were analyzed in 3 evaluation periods (2010, 2012 and 2015), addressing quality indicators for diagnosis, treatment, and treatment outcomes.

Results

Overall, 118,795 patients who presented any data points were included. All quality indicators (number of IPSS and PSA determinations) increased between the first period and the last. Combination (alpha-blocker + 5-ARI) therapy was increasingly prescribed during the study periods whereas the proportion of prescriptions for single-agent alpha-blocker showed no significant differences among the periods analyzed. However, the total number of patients eligible for combination therapy who actually received this treatment was low in all periods (7.5, 17.9, and 20.1%, in 2010, 2012, and 2015, respectively). The outcome indicators revealed a decrease in referrals to the Urology unit mostly among newly diagnosed patients. Even though the proportion of patients who underwent BPH-related surgeries increased significantly from the first to the second period, the number of surgeries remained stable between the second and third periods.

Conclusions

The training program had a generally positive impact on the management of BPH patients in primary care, but the overall study period may be insufficient to show an effect on some outcome indicators such as the number of surgeries.

导言和目标:为提高全科医生对良性前列腺增生症(BPH)优化管理的参与度,我们制定了一项培训计划。本研究旨在评估培训计划实施后良性前列腺增生症管理方面的变化。材料与方法本观察性回顾性队列研究于 2019 年至 2020 年间进行。对 3 个评估期(2010 年、2012 年和 2015 年)的汇总数据进行了分析,涉及诊断、治疗和治疗结果的质量指标。所有质量指标(IPSS和PSA测定次数)在第一个评估期和最后一个评估期之间都有所增加。在研究期间,联合疗法(α-受体阻滞剂 + 5-ARI)的处方量越来越多,而单药α-受体阻滞剂的处方比例在分析期间没有明显差异。然而,在所有研究期间,符合联合治疗条件并实际接受这种治疗的患者总人数较少(2010 年、2012 年和 2015 年分别为 7.5%、17.9% 和 20.1%)。结果指标显示,转诊到泌尿科的患者有所减少,其中大部分是新确诊的患者。尽管接受良性前列腺增生相关手术的患者比例从第一期到第二期显著增加,但手术数量在第二期和第三期之间保持稳定。
{"title":"Nuevas pautas de actuación en la hiperplasia benigna de próstata en la Comunidad Valenciana: un estudio de vida real","authors":"J. Navarro-Pérez ,&nbsp;E. López Alcina ,&nbsp;J. Calabuig Pérez ,&nbsp;F. Brotons Muntó ,&nbsp;A. Martínez ,&nbsp;L. Vallejo ,&nbsp;J. Jiménez","doi":"10.1016/j.acuro.2023.11.006","DOIUrl":"10.1016/j.acuro.2023.11.006","url":null,"abstract":"<div><h3>Introduction and objectives</h3><p>A training program was developed to increase general practitioners’ engagement in the optimal management of benign prostatic hyperplasia (BPH). The goal of this study was to evaluate changes in BPH management after the implementation of a training program.</p></div><div><h3>Material and methods</h3><p>This observational retrospective cohort study was conducted between 2019 and 2020. Aggregated data were analyzed in 3 evaluation periods (2010, 2012 and 2015), addressing quality indicators for diagnosis, treatment, and treatment outcomes.</p></div><div><h3>Results</h3><p>Overall, 118,795 patients who presented any data points were included. All quality indicators (number of IPSS and PSA determinations) increased between the first period and the last. Combination (alpha-blocker<!--> <!-->+<!--> <!-->5-ARI) therapy was increasingly prescribed during the study periods whereas the proportion of prescriptions for single-agent alpha-blocker showed no significant differences among the periods analyzed. However, the total number of patients eligible for combination therapy who actually received this treatment was low in all periods (7.5, 17.9, and 20.1%, in 2010, 2012, and 2015, respectively). The outcome indicators revealed a decrease in referrals to the Urology unit mostly among newly diagnosed patients. Even though the proportion of patients who underwent BPH-related surgeries increased significantly from the first to the second period, the number of surgeries remained stable between the second and third periods.</p></div><div><h3>Conclusions</h3><p>The training program had a generally positive impact on the management of BPH patients in primary care, but the overall study period may be insufficient to show an effect on some outcome indicators such as the number of surgeries.</p></div>","PeriodicalId":7145,"journal":{"name":"Actas urologicas espanolas","volume":"48 6","pages":"Pages 461-469"},"PeriodicalIF":1.2,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0210480623001717/pdfft?md5=ad5b4c9c4deeca22a92e1c1ca3d356c8&pid=1-s2.0-S0210480623001717-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139189206","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nuevas fronteras en el trasplante renal: hacia la realidad extendida 肾移植的新前沿:走向扩展的现实
IF 1.1 4区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2024-06-01 DOI: 10.1016/j.acuro.2023.10.003
A. Piana , A. Pecoraro , M.I. Dönmez , T. Prudhomme , B. Bañuelos Marco , A. López Abad , R. Campi , R. Boissier , E. Checcucci , D. Amparore , F. Porpiglia , A. Breda , A. Territo , en representación del grupo de trasplante renal de la sección de Jóvenes Urólogos Académicos (YAU) de la Asociación Europea de Urología (EAU)
{"title":"Nuevas fronteras en el trasplante renal: hacia la realidad extendida","authors":"A. Piana ,&nbsp;A. Pecoraro ,&nbsp;M.I. Dönmez ,&nbsp;T. Prudhomme ,&nbsp;B. Bañuelos Marco ,&nbsp;A. López Abad ,&nbsp;R. Campi ,&nbsp;R. Boissier ,&nbsp;E. Checcucci ,&nbsp;D. Amparore ,&nbsp;F. Porpiglia ,&nbsp;A. Breda ,&nbsp;A. Territo ,&nbsp;en representación del grupo de trasplante renal de la sección de Jóvenes Urólogos Académicos (YAU) de la Asociación Europea de Urología (EAU)","doi":"10.1016/j.acuro.2023.10.003","DOIUrl":"10.1016/j.acuro.2023.10.003","url":null,"abstract":"","PeriodicalId":7145,"journal":{"name":"Actas urologicas espanolas","volume":"48 5","pages":"Pages 337-339"},"PeriodicalIF":1.1,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136160580","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Actas urologicas espanolas
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1